코골이 방지 기기 및 코골이 수술 시장 규모, 점유율＆동향 분석 리포트 : 유형별(구강내 장치/마우스피스, 위치제어장치), 지역별(아시아태평양, 유럽, 북미), 부문별 예측(2022-2030년)

Anti-snoring Devices & Snoring Surgery Market Growth & Trends:

The global anti-snoring devices and snoring surgery market size is expected to reach USD 2.65 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to register a significant CAGR of 7.2% over the forecast period. Increasing focus on developing new products in the market by the key players is expected to boost the growth of the market. In addition, the ever-rising cases of snoring issues and sleep apnea are also expected to propel the growth of the market over the forecast period. For instance, according to the American Sleep Association, about 50-70 million U.S. adults have a sleep disorder and 48% of this report snoring.

Various restrictions laid down by the government as an attempt to curb the spread of the COVID-19 virus led to a major loss across the majority of industries. While the restriction on traveling and movement led to a major disruption in the supply of products and services, it also led to reduced patient visits to the hospitals and clinics. Thus, the pandemic had a huge impact on the healthcare industry. The global market felt a slight yet significant negative impact too. The reduced patient visits to the hospitals and clinics further led to a reduced number of patients seeking treatment for snoring. However, with the world returning to normalcy and manufacturers focusing on new and advanced product development, the market is expected to experience considerable growth over the forecast period.

Anti-snoring Devices & Snoring Surgery Market Report Highlights:

• Based on type, the oral appliances/mouthpieces segment dominated the global market in 2021

• The high share of the segment was attributed to the increased adoption of oral appliances/mouthpieces as they are often recommended as the first line of treatment

• The COVID-19 pandemic had a slight negative impact due to reduced patient visits to the hospitals and clinics to seek a proper treatment regime

• With the majority of countries moving towards digital technology and e-commerce, the market players have a higher chance of increasing their product reach and market penetration

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Type
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Anti-Snoring Devices and Snoring Surgery Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market driver analysis
    • 3.4.1.1. Rising geriatric and obese population
    • 3.4.1.2. Presence of untapped population pool
    • 3.4.1.3. New product launches and regulatory approvals
  • 3.4.2. Market restraint analysis
    • 3.4.2.1. Unfavorable regulatory scenario
    • 3.4.2.2. High cost of surgeries
• 3.5. Anti-snoring Devices and Snoring Surgery Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's Five Forces
    • 3.5.1.1.Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape
  • 3.5.3. Major Deals & Strategic Alliances Analysis
  • 3.5.4. Market Entry Strategies

Chapter 4. Anti-snoring Devices and Snoring Surgery: Type Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Oral appliances/mouthpieces
  • 4.1.2. Nasal Devices
  • 4.1.3. Position Control Devices
  • 4.1.4. Chin Straps
  • 4.1.5. Tongue Stabilizing Devices
  • 4.1.6. EPAP Therapy Devices
• 4.2. Type Market Share, 2021 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Anti-snoring Devices and Snoring Surgery Market by Type Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
  • 4.5.1. Oral appliances/mouthpieces
    • 4.5.1.1. Market estimates and forecast 2017 to 2030 (USD Million)
  • 4.5.2. Nasal devices
    • 4.5.2.1. Market estimates and forecast 2017 to 2030 (USD Million)
  • 4.5.3. Position control devices
    • 4.5.3.1. Market estimates and forecast 2017 to 2030 (USD Million)
  • 4.5.4. Chin straps
    • 4.5.4.1. Market estimates and forecast 2017 to 2030 (USD Million)
  • 4.5.5. Tongue stabilizing devices
    • 4.5.5.1. Market estimates and forecast 2017 to 2030 (USD Million)
  • 4.5.6. EPAP therapy devices
    • 4.5.6.1. Market estimates and forecast 2017 to 2030 (USD Million)

Chapter 5. Anti-snoring Devices and Snoring Surgery Market: Regional Estimates & Trend Analysis

• 5.1. Regional market share analysis, 2021 & 2030
• 5.2. Regional Market Dashboard
• 5.3. Global Regional Market Snapshot
• 5.4. Regional Market Share and Leading Players, 2021
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East and Africa
• 5.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East and Africa
• 5.6. Market Size, & Forecasts, Volume and Trend Analysis, 2017 to 2030
• 5.7. North America
  • 5.7.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
  • 5.7.2. U.S.
    • 5.7.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
  • 5.7.3. Canada
    • 5.7.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
• 5.8. Europe
  • 5.8.1. U.K.
    • 5.8.1.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
  • 5.8.2. Germany
    • 5.8.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
  • 5.8.3. France
    • 5.8.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
  • 5.8.4. Italy
    • 5.8.4.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
  • 5.8.5. Spain
    • 5.8.5.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
• 5.9. Asia Pacific
  • 5.9.1. China
    • 5.9.1.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
  • 5.9.2. Japan
    • 5.9.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
  • 5.9.3. India
    • 5.9.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
  • 5.9.4. Australia
    • 5.9.4.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
  • 5.9.5. South Korea
    • 5.9.5.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
• 5.10. Latin America
  • 5.10.1. Brazil
    • 5.10.1.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
  • 5.10.2. Mexico
    • 5.10.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
  • 5.10.3. Argentina
    • 5.10.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
• 5.11. MEA
  • 5.11.1. Saudi Arabia
    • 5.11.1.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
  • 5.11.2. South Africa
    • 5.11.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
  • 5.11.3. UAE
    • 5.11.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
  • 6.2.1. Innovators
• 6.3. Apnea Sciences Corporation
  • 6.3.1. List of key distributors and channel partners
  • 6.3.2. Key customers
  • 6.3.3. Key company market share analysis, 2021
  • 6.3.4. Ocular Therapeutix Inc
    • 6.3.4.1. Company overview
    • 6.3.4.2. Financial performance
    • 6.3.4.3. Product benchmarking
    • 6.3.4.4. Strategic initiatives
  • 6.3.5. SomnoMed Ltd.
    • 6.3.5.1. Company overview
    • 6.3.5.2. Financial performance
    • 6.3.5.3. Product benchmarking
    • 6.3.5.4. Strategic initiatives
  • 6.3.6. Airway Management, Inc.
    • 6.3.6.1. Company overview
    • 6.3.6.2. Financial performance
    • 6.3.6.3. Product benchmarking
    • 6.3.6.4. Strategic initiatives
  • 6.3.7. Resmed Inc.
    • 6.3.7.1. Company overview
    • 6.3.7.2. Financial performance
    • 6.3.7.3. Product benchmarking
    • 6.3.7.4. Strategic initiatives
  • 6.3.8. Fisher & Paykel Healthcare Corp. Ltd.
    • 6.3.8.1. Company overview
    • 6.3.8.2. Financial performance
    • 6.3.8.3. Product benchmarking
    • 6.3.8.4. Strategic initiatives
  • 6.3.9. Koninklijke Philips NV
    • 6.3.9.1. Company overview
    • 6.3.9.2. Financial performance
    • 6.3.9.3. Product benchmarking
    • 6.3.9.4. Strategic initiatives
  • 6.3.10. Sleep Well Enjoy Life, Ltd.
    • 6.3.10.1. Company overview
    • 6.3.10.2. Financial performance
    • 6.3.10.3. Product benchmarking
    • 6.3.10.4. Strategic initiatives
  • 6.3.11. Tomed Dr. Toussaint GmbH
    • 6.3.11.1. Company overview
    • 6.3.11.2. Financial performance
    • 6.3.11.3. Product benchmarking
    • 6.3.11.4. Strategic initiatives
  • 6.3.12. MEDiTAS Ltd.
    • 6.3.12.1. Company overview
    • 6.3.12.2. Financial performance
    • 6.3.12.3. Product benchmarking
    • 6.3.12.4. Strategic initiatives